We were excited to present our work titled, “Biomimetic, Antibiotic Free, Nanoparticles for Agent Agnostic Broad Spectrum Antimicrobial Action including ESKAPE Pathogens” [Abstract 557] at the 2023 TechConnect World Innovation Conference in National Harbor, MD (June 19-21, 2023), as part of the Precision Health and Diagnostics symposium.
Our talk was well received. We got lots of useful pointers on commercialization pathways and IND filing at the FDA.
I am also excited to have chaired this session on #precisionhealth at #techconnect2023 and have Roy Stillwell, co-founder of #NotreDame#startup Nearwave, be the keynote speaker about their revolutionary non-invasive diagnostic instrument. @ND_IPH @UNDResearch
Recent Comments